Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
BYSI
website
Price
-
Market Cap
25.91 M
Float
35.75 M
Country
-
Sector
-
Exchange
-
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about BYSI
BYSI
Price
$0.00
BYSI
1D
1W
1M
3M
Company
About
Description
Sector
-
Industry
-
Country
-
Exchange
Vol Avg.
N/A
Inst Own
9.200%
Float & OS
35.75 M / 41.12 M
Cash/Shr
$0.027
Market Cap & Ev
Short Interest
6.6%
Borrow Rate
6.6416%
Days to Cover
35.77
Ofr Ability
Ofr Freq.
Dilution
Cash Need
Overall Offering Risk
Warrant Exercise Risk
Research Report
Customize research
Recent Articles (8)
View All
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
Globe Newswire
Sep 29, 2026, 7:01 AM
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire
Aug 14, 2026, 5:15 PM
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
Globe Newswire
Jun 4, 2026, 7:00 AM
BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026
Globe Newswire
Jun 2, 2026, 7:00 AM
BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting
Globe Newswire
May 18, 2026, 7:00 AM
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire
May 13, 2026, 7:00 AM
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
Globe Newswire
Apr 22, 2026, 7:00 AM
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
Globe Newswire
Mar 30, 2026, 7:30 AM
Recent Filings
View All
Type
Title
Date Released
Earnings
Dec
17
Q4 2026
Earnings report
Upcoming
Nov
12
Q4 2026
Earnings report
Upcoming
Aug
14
Q3 2026
Earnings report
-0.02%
beat
May
13
Q2 2026
Earnings report
-0.05%
beat
Mar
25
Q1 2026
Earnings report
-0.05%
beat
Nov
12
Q4 2025
Earnings report
-0.05%
missed
Related Healthcare stocks
All tickers
ABVC
ABVC BioPharma
CVM
CEL-SCI
AARD
Aardvark Therapeutics, Inc. Common Stock
RNAZ
TransCode Therapeutics
MGX
Metagenomi, Inc. Common Stock
CELU
Celularity
NXTC
NextCure
PLRZ
Polyrizon
EVAX
Evaxion Biotech A/S
ESLA
Estrella Immunopharma
IXHL
Incannex Healthcare
ACET
Adicet Bio
